Table 5 IgG avidity in symptomatic infants suspected of cCMV older than 1 to 12 months of age
Year | CMV IgM | N | IgG avidity | ||
|---|---|---|---|---|---|
Low AI N (%) | Equivocal AI N (%) | High AI N(%) | |||
2016 | Positive | 7 | 2 (28.5%) | 2 (28.5%) | 3 (42.8%) |
Borderline | 8 | 2 (25%) | 5 (62.5%) | 1 (12.5%) | |
2017 | Positive | 11 | 2 (18.1%) | 3 (27.7%) | 6 (54.5%) |
Borderline | 14 | 2 (14.2%) | 6 (42.8%) | 6 (42.8%) | |
Total | Positive | 18 | 4 (22.2%) | 5 (27.7%) | 9 (50%) |
Borderline | 22 | 4 (18.1%) | 11 (50%) | 7 (31.8%) | |
Positive and Borderline | 8 (20%) | 16 (40%) | 16 (40%) | ||